Survival rates lower among African Americans with colon cancer
the ONA take:
African Americans with colon cancer have lower survival rates compared with white patients, despite an overall decline in colon cancer deaths.
However, delivering evidence-based care within an integrated health care system can improve survival rates for this population.
Investigators from the Stanford University School of Medicine evaluated the records of more than 30,000 patients with colon cancer who underwent treatment for their disease, comparing the care delivery with recommendations from the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology for Colon Cancer.
Their study results demonstrated that better overall survival rates were seen in all patients, including minorities, treated with integrated health systems—includes hospital-based care, outpatient services, and rehabilitation.
The investigators conclude that providing evidence-based care that follows the sequential management decisions outlined in the NCCN Guidelines can equalize racial disparities and improve care for all patients.
African Americans with colon cancer have lower survival rates compared with white patients.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Immunotherapy and the Future of Prostate Cancer Treatment
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Use of Checkpoint Inhibitors in Urothelial Carcinoma
- Chemo + Radiotherapy Efficacious in Muscle-invasive Bladder Cancer
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Colorectal Cancer Risk Higher With Poor Metabolic Health vs Increased Weight
- Best Approach to Infection and Tumor Treatment: Contain or Eliminate?
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|